Home>Healthcare>Medical Care>Prostate Specific Antigen (PSA) Testing Market, Global Outlook and Forecast 2022-2028

Prostate Specific Antigen (PSA) Testing Market, Global Outlook and Forecast 2022-2028

Healthcare Fraud Detection Software Market

Product Id: 61565

SKU: 51940

Categories:

Publisher:

No. of Pages: 100
Published Date: 04/14/2022

Request Sample

Single User Licence

PRICE $3,250.00

Corporate Licence

Enquire Now

Report Summary

Prostate Specific Antigen (PSA) Testing Market

Introduction:

Prostate Specific Antigen (PSA) testing is a medical procedure used to measure the levels of a protein called prostate-specific antigen in a man’s blood. The prostate is a small gland located below the bladder and in front of the rectum in males. It produces a fluid that is a component of semen. PSA is a protein produced by both normal and cancerous cells in the prostate gland, and it plays a role in liquefying semen, which aids in sperm mobility.

Market Analysis:

The PSA testing market has experienced steady growth over the years, primarily driven by factors such as increasing awareness about prostate cancer, aging populations in many countries, and advancements in medical technology. Prostate cancer is one of the most common cancers among men, and the demand for early detection and monitoring has contributed to the growth of the PSA testing market.

Drivers:

  1. Prevalence of Prostate Cancer: Prostate cancer is one of the most common cancers in men. The high prevalence of prostate cancer globally has driven the demand for effective screening and diagnostic tools, with PSA testing being one of the primary methods.
  2. Aging Population: The risk of prostate cancer increases with age. As populations in many countries are aging, there is a growing demographic of older men who are more likely to require prostate cancer screening and monitoring.

Restraints:

  1. Overdiagnosis and Overtreatment: One of the most significant challenges is the potential for overdiagnosis and overtreatment of prostate cancer. PSA testing can identify slow-growing cancers that may never cause harm, leading to unnecessary interventions and treatment with potential side effects.
  2. False Positives and False Negatives: PSA testing can produce false positive results, indicating cancer when there isn’t any, and false negative results, missing cancer that is present. These inaccuracies can lead to unnecessary anxiety or delayed diagnosis and treatment.
This report contains market size and forecasts of Prostate Specific Antigen (PSA) Testing in Global, including the following market information:
Global Prostate Specific Antigen (PSA) Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Specific Antigen (PSA) Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radioimmunoassay Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Specific Antigen (PSA) Testing include Cleveland Diagnostics, Abbott, Siemens Healthineers, DiaSorin, Roche Holding AG, Beckman Coulter, Mediwatch(LABORIE), Boditech and Bristol Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Specific Antigen (PSA) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Specific Antigen (PSA) Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, by Type, 2021 (%)
Radioimmunoassay
Enzyme Immunoassay
Global Prostate Specific Antigen (PSA) Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others
Global Prostate Specific Antigen (PSA) Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Specific Antigen (PSA) Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Specific Antigen (PSA) Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cleveland Diagnostics
Abbott
Siemens Healthineers
DiaSorin
Roche Holding AG
Beckman Coulter
Mediwatch(LABORIE)
Boditech
Bristol Myers Squibb
GE Healthcare
Endocare
GlaxoSmith Kline
Anixa Biosciences
Ortho Clinical
Fujirebio
Merck

Description

This report contains market size and forecasts of Prostate Specific Antigen (PSA) Testing in Global, including the following market information:
Global Prostate Specific Antigen (PSA) Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Prostate Specific Antigen (PSA) Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period 2022-2028.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radioimmunoassay Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Prostate Specific Antigen (PSA) Testing include Cleveland Diagnostics, Abbott, Siemens Healthineers, DiaSorin, Roche Holding AG, Beckman Coulter, Mediwatch(LABORIE), Boditech and Bristol Myers Squibb, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prostate Specific Antigen (PSA) Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prostate Specific Antigen (PSA) Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, by Type, 2021 (%)
Radioimmunoassay
Enzyme Immunoassay
Global Prostate Specific Antigen (PSA) Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Diagnostic Centers
Research Institute
Others
Global Prostate Specific Antigen (PSA) Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Prostate Specific Antigen (PSA) Testing Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prostate Specific Antigen (PSA) Testing revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Prostate Specific Antigen (PSA) Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Cleveland Diagnostics
Abbott
Siemens Healthineers
DiaSorin
Roche Holding AG
Beckman Coulter
Mediwatch(LABORIE)
Boditech
Bristol Myers Squibb
GE Healthcare
Endocare
GlaxoSmith Kline
Anixa Biosciences
Ortho Clinical
Fujirebio
Merck

Table of Content

1 Introduction to Research & Analysis Reports
1.1 Prostate Specific Antigen (PSA) Testing Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prostate Specific Antigen (PSA) Testing Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prostate Specific Antigen (PSA) Testing Overall Market Size
2.1 Global Prostate Specific Antigen (PSA) Testing Market Size: 2021 VS 2028
2.2 Global Prostate Specific Antigen (PSA) Testing Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Prostate Specific Antigen (PSA) Testing Players in Global Market
3.2 Top Global Prostate Specific Antigen (PSA) Testing Companies Ranked by Revenue
3.3 Global Prostate Specific Antigen (PSA) Testing Revenue by Companies
3.4 Top 3 and Top 5 Prostate Specific Antigen (PSA) Testing Companies in Global Market, by Revenue in 2021
3.5 Global Companies Prostate Specific Antigen (PSA) Testing Product Type
3.6 Tier 1, Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Testing Players in Global Market
3.6.1 List of Global Tier 1 Prostate Specific Antigen (PSA) Testing Companies
3.6.2 List of Global Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Testing Companies
4 Market Sights by Product
4.1 Overview
4.1.1 by Type – Global Prostate Specific Antigen (PSA) Testing Market Size Markets, 2021 & 2028
4.1.2 Radioimmunoassay
4.1.3 Enzyme Immunoassay
4.2 By Type – Global Prostate Specific Antigen (PSA) Testing Revenue & Forecasts
4.2.1 By Type – Global Prostate Specific Antigen (PSA) Testing Revenue, 2017-2022
4.2.2 By Type – Global Prostate Specific Antigen (PSA) Testing Revenue, 2023-2028
4.2.3 By Type – Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prostate Specific Antigen (PSA) Testing Market Size, 2021 & 2028
5.1.2 Hospitals
5.1.3 Clinics
5.1.4 Diagnostic Centers
5.1.5 Research Institute
5.1.6 Others
5.2 By Application – Global Prostate Specific Antigen (PSA) Testing Revenue & Forecasts
5.2.1 By Application – Global Prostate Specific Antigen (PSA) Testing Revenue, 2017-2022
5.2.2 By Application – Global Prostate Specific Antigen (PSA) Testing Revenue, 2023-2028
5.2.3 By Application – Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
6 Sights by Region
6.1 By Region – Global Prostate Specific Antigen (PSA) Testing Market Size, 2021 & 2028
6.2 By Region – Global Prostate Specific Antigen (PSA) Testing Revenue & Forecasts
6.2.1 By Region – Global Prostate Specific Antigen (PSA) Testing Revenue, 2017-2022
6.2.2 By Region – Global Prostate Specific Antigen (PSA) Testing Revenue, 2023-2028
6.2.3 By Region – Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country – North America Prostate Specific Antigen (PSA) Testing Revenue, 2017-2028
6.3.2 US Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.3.3 Canada Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.3.4 Mexico Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.4 Europe
6.4.1 By Country – Europe Prostate Specific Antigen (PSA) Testing Revenue, 2017-2028
6.4.2 Germany Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.4.3 France Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.4.4 U.K. Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.4.5 Italy Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.4.6 Russia Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.4.7 Nordic Countries Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.4.8 Benelux Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.5 Asia
6.5.1 By Region – Asia Prostate Specific Antigen (PSA) Testing Revenue, 2017-2028
6.5.2 China Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.5.3 Japan Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.5.4 South Korea Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.5.5 Southeast Asia Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.5.6 India Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.6 South America
6.6.1 By Country – South America Prostate Specific Antigen (PSA) Testing Revenue, 2017-2028
6.6.2 Brazil Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.6.3 Argentina Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country – Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue, 2017-2028
6.7.2 Turkey Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.7.3 Israel Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.7.4 Saudi Arabia Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
6.7.5 UAE Prostate Specific Antigen (PSA) Testing Market Size, 2017-2028
7 Players Profiles
7.1 Cleveland Diagnostics
7.1.1 Cleveland Diagnostics Corporate Summary
7.1.2 Cleveland Diagnostics Business Overview
7.1.3 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.1.4 Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.1.5 Cleveland Diagnostics Key News
7.2 Abbott
7.2.1 Abbott Corporate Summary
7.2.2 Abbott Business Overview
7.2.3 Abbott Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.2.4 Abbott Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.2.5 Abbott Key News
7.3 Siemens Healthineers
7.3.1 Siemens Healthineers Corporate Summary
7.3.2 Siemens Healthineers Business Overview
7.3.3 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.3.4 Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.3.5 Siemens Healthineers Key News
7.4 DiaSorin
7.4.1 DiaSorin Corporate Summary
7.4.2 DiaSorin Business Overview
7.4.3 DiaSorin Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.4.4 DiaSorin Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.4.5 DiaSorin Key News
7.5 Roche Holding AG
7.5.1 Roche Holding AG Corporate Summary
7.5.2 Roche Holding AG Business Overview
7.5.3 Roche Holding AG Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.5.4 Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.5.5 Roche Holding AG Key News
7.6 Beckman Coulter
7.6.1 Beckman Coulter Corporate Summary
7.6.2 Beckman Coulter Business Overview
7.6.3 Beckman Coulter Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.6.4 Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.6.5 Beckman Coulter Key News
7.7 Mediwatch(LABORIE)
7.7.1 Mediwatch(LABORIE) Corporate Summary
7.7.2 Mediwatch(LABORIE) Business Overview
7.7.3 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.7.4 Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.7.5 Mediwatch(LABORIE) Key News
7.8 Boditech
7.8.1 Boditech Corporate Summary
7.8.2 Boditech Business Overview
7.8.3 Boditech Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.8.4 Boditech Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.8.5 Boditech Key News
7.9 Bristol Myers Squibb
7.9.1 Bristol Myers Squibb Corporate Summary
7.9.2 Bristol Myers Squibb Business Overview
7.9.3 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.9.4 Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.9.5 Bristol Myers Squibb Key News
7.10 GE Healthcare
7.10.1 GE Healthcare Corporate Summary
7.10.2 GE Healthcare Business Overview
7.10.3 GE Healthcare Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.10.4 GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.10.5 GE Healthcare Key News
7.11 Endocare
7.11.1 Endocare Corporate Summary
7.11.2 Endocare Business Overview
7.11.3 Endocare Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.11.4 Endocare Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.11.5 Endocare Key News
7.12 GlaxoSmith Kline
7.12.1 GlaxoSmith Kline Corporate Summary
7.12.2 GlaxoSmith Kline Business Overview
7.12.3 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.12.4 GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.12.5 GlaxoSmith Kline Key News
7.13 Anixa Biosciences
7.13.1 Anixa Biosciences Corporate Summary
7.13.2 Anixa Biosciences Business Overview
7.13.3 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.13.4 Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.13.5 Anixa Biosciences Key News
7.14 Ortho Clinical
7.14.1 Ortho Clinical Corporate Summary
7.14.2 Ortho Clinical Business Overview
7.14.3 Ortho Clinical Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.14.4 Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.14.5 Ortho Clinical Key News
7.15 Fujirebio
7.15.1 Fujirebio Corporate Summary
7.15.2 Fujirebio Business Overview
7.15.3 Fujirebio Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.15.4 Fujirebio Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.15.5 Fujirebio Key News
7.16 Merck
7.16.1 Merck Corporate Summary
7.16.2 Merck Business Overview
7.16.3 Merck Prostate Specific Antigen (PSA) Testing Major Product Offerings
7.16.4 Merck Prostate Specific Antigen (PSA) Testing Revenue in Global Market (2017-2022)
7.16.5 Merck Key News
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List of Tables & Figures

List of Tables
Table 1. Prostate Specific Antigen (PSA) Testing Market Opportunities & Trends in Global Market
Table 2. Prostate Specific Antigen (PSA) Testing Market Drivers in Global Market
Table 3. Prostate Specific Antigen (PSA) Testing Market Restraints in Global Market
Table 4. Key Players of Prostate Specific Antigen (PSA) Testing in Global Market
Table 5. Top Prostate Specific Antigen (PSA) Testing Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Prostate Specific Antigen (PSA) Testing Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Prostate Specific Antigen (PSA) Testing Revenue Share by Companies, 2017-2022
Table 8. Global Companies Prostate Specific Antigen (PSA) Testing Product Type
Table 9. List of Global Tier 1 Prostate Specific Antigen (PSA) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prostate Specific Antigen (PSA) Testing Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type – Prostate Specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type – Prostate Specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application – Prostate Specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application – Prostate Specific Antigen (PSA) Testing Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region – Global Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), 2017-2022
Table 19. By Region – Global Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), 2023-2028
Table 20. By Country – North America Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
Table 21. By Country – North America Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
Table 22. By Country – Europe Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
Table 23. By Country – Europe Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
Table 24. By Region – Asia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
Table 25. By Region – Asia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
Table 26. By Country – South America Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
Table 27. By Country – South America Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
Table 28. By Country – Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2022
Table 29. By Country – Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2023-2028
Table 30. Cleveland Diagnostics Corporate Summary
Table 31. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Product Offerings
Table 32. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 33. Abbott Corporate Summary
Table 34. Abbott Prostate Specific Antigen (PSA) Testing Product Offerings
Table 35. Abbott Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 36. Siemens Healthineers Corporate Summary
Table 37. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Product Offerings
Table 38. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 39. DiaSorin Corporate Summary
Table 40. DiaSorin Prostate Specific Antigen (PSA) Testing Product Offerings
Table 41. DiaSorin Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 42. Roche Holding AG Corporate Summary
Table 43. Roche Holding AG Prostate Specific Antigen (PSA) Testing Product Offerings
Table 44. Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 45. Beckman Coulter Corporate Summary
Table 46. Beckman Coulter Prostate Specific Antigen (PSA) Testing Product Offerings
Table 47. Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 48. Mediwatch(LABORIE) Corporate Summary
Table 49. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Product Offerings
Table 50. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 51. Boditech Corporate Summary
Table 52. Boditech Prostate Specific Antigen (PSA) Testing Product Offerings
Table 53. Boditech Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 54. Bristol Myers Squibb Corporate Summary
Table 55. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Product Offerings
Table 56. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 57. GE Healthcare Corporate Summary
Table 58. GE Healthcare Prostate Specific Antigen (PSA) Testing Product Offerings
Table 59. GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 60. Endocare Corporate Summary
Table 61. Endocare Prostate Specific Antigen (PSA) Testing Product Offerings
Table 62. Endocare Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 63. GlaxoSmith Kline Corporate Summary
Table 64. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Product Offerings
Table 65. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 66. Anixa Biosciences Corporate Summary
Table 67. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Product Offerings
Table 68. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 69. Ortho Clinical Corporate Summary
Table 70. Ortho Clinical Prostate Specific Antigen (PSA) Testing Product Offerings
Table 71. Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 72. Fujirebio Corporate Summary
Table 73. Fujirebio Prostate Specific Antigen (PSA) Testing Product Offerings
Table 74. Fujirebio Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
Table 75. Merck Corporate Summary
Table 76. Merck Prostate Specific Antigen (PSA) Testing Product Offerings
Table 77. Merck Prostate Specific Antigen (PSA) Testing Revenue (US$, Mn), (2017-2022)
List of Figures
Figure 1. Prostate Specific Antigen (PSA) Testing Segment by Type in 2021
Figure 2. Prostate Specific Antigen (PSA) Testing Segment by Application in 2021
Figure 3. Global Prostate Specific Antigen (PSA) Testing Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Prostate Specific Antigen (PSA) Testing Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Prostate Specific Antigen (PSA) Testing Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Prostate Specific Antigen (PSA) Testing Revenue in 2021
Figure 8. By Type – Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
Figure 9. By Application – Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
Figure 10. By Region – Global Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
Figure 11. By Country – North America Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
Figure 12. US Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 15. By Country – Europe Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
Figure 16. Germany Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 17. France Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 23. By Region – Asia Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
Figure 24. China Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 28. India Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 29. By Country – South America Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
Figure 30. Brazil Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 32. By Country – Middle East & Africa Prostate Specific Antigen (PSA) Testing Revenue Market Share, 2017-2028
Figure 33. Turkey Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Prostate Specific Antigen (PSA) Testing Revenue, (US$, Mn), 2017-2028
Figure 37. Cleveland Diagnostics Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Abbott Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Siemens Healthineers Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. DiaSorin Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Roche Holding AG Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Beckman Coulter Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Mediwatch(LABORIE) Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Boditech Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Bristol Myers Squibb Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. GE Healthcare Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Endocare Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. GlaxoSmith Kline Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Anixa Biosciences Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Ortho Clinical Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Fujirebio Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 52. Merck Prostate Specific Antigen (PSA) Testing Revenue Year Over Year Growth (US$, Mn) & (2017-2022)

Request Sample Report

Request Sample Form

Please fill in the form to request a sample report

Related Reports

Are you facing any problem?

If you are finding it difficult to search for the market research report that you need for your business, you can either write to us or request a custom compiled research report.

Request Custom Reports
View All Categories